Assessment of survival and cardiotoxicity of adjuvant trastuzumab among HER2 breast cancer patients in an oncology centre in Malaysia / Harissa H Hasbullah … [et al.]

Adjuvant trastuzumab has been used in human epidermal growth factor-2 (HER2) breast cancer to improve survival but with concern of cardiotoxicity. Our study is the first to review efficacy and toxicity of adjuvant trastuzumab in Malaysia. Methods: This is a retrospective cohort study on HER2 non met...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasbullah, Harissa H, Bustamam, Anita, Tho, Lye Munn, Phua, Vincent
Format: Article
Language:English
Published: Universiti Teknologi MARA Cawangan Selangor 2018
Subjects:
Online Access:http://ir.uitm.edu.my/id/eprint/30061/1/AJ_HARISSA%20H.%20ABDULLAH%20JCHC%20B%2018.pdf
http://ir.uitm.edu.my/id/eprint/30061/
https://jchs-medicine.uitm.edu.my/images/manuscript/vol3issue1/original-articles/p33-42/Assessment-of-Survival-and-Cardiotoxicity-of-Adjuvant-Trastuzumab-among-HER2-Breast-Cancer-Patients-in-an-Oncology-Centre-in-Malaysia.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!